Vical
20
0
0
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
4 terminated/withdrawn out of 20 trials
80.0%
-6.5% vs industry average
15%
3 trials in Phase 3/4
6%
1 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor
Role: collaborator
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Role: collaborator
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
Role: collaborator
Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)
Role: lead
Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
Role: lead
A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma
Role: lead
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults
Role: lead
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
Role: lead
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
Role: collaborator
Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease
Role: collaborator
Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
Role: lead
Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Role: lead
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Role: lead
Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
Role: lead
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Role: lead
Pandemic Influenza Plasmid DNA Vaccines (Needle)
Role: lead
Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Role: lead
Phase II Trial of Allovectin-7® for Head and Neck Cancer
Role: lead
Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge
Role: collaborator
Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM
Role: collaborator
All 20 trials loaded